SEC Fines COVID Test Maker, Execs Over Disclosures
A molecular diagnostics company and its current and former executives have agreed to settle U.S. Securities and Exchange Commission claims that they issued two misleading press releases concerning a COVID-19 screening...To view the full article, register now.
Already a subscriber? Click here to view full article